Attached files
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statements (Form S-8 Nos. 333-201036, 333-216656, 333-218772 and 333-220170) pertaining to the 2006 Stock Option Plan, 2011 Stock Option Plan, 2014 Equity Incentive Plan, as amended, and 2014 Employee Stock Purchase Plan of Bellicum Pharmaceuticals, Inc., and |
(2) | Registration Statements (Form S-3 Nos. 333-219021 and 333-219020) of Bellicum Pharmaceuticals, Inc. |
of our report dated March 13, 2018, with respect to the consolidated financial statements of Bellicum Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Bellicum Pharmaceuticals, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Houston, Texas
March 13, 2018